Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Minority Interest (2025)

Vivos Therapeutics' Minority Interest history spans 1 years, with the latest figure at -$60000.0 for Q4 2025.

  • Quarterly results put Minority Interest at -$60000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$60000.0 (changed N/A YoY), and the annual figure for FY2025 was -$60000.0, changed.
  • Minority Interest for Q4 2025 was -$60000.0 at Vivos Therapeutics.
  • In the past five years, Minority Interest ranged from a high of -$60000.0 in Q4 2025 to a low of -$60000.0 in Q4 2025.